title: Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling.
abstract: The bulk of familial breast cancer risk (∼70%) cannot be explained by mutations in the known predisposition genes, primarily BRCA1 and BRCA2. Underlying genetic heterogeneity in these cases is the probable explanation for the failure of all attempts to identify further high-risk alleles. While exome sequencing of non-BRCA1/2 breast cancer cases is a promising strategy to detect new high-risk genes, rational approaches to the rigorous pre-selection of cases are needed to reduce heterogeneity. We selected six families in which the tumours of multiple cases showed a specific genomic profile on array comparative genomic hybridization (aCGH). Linkage analysis in these families revealed a region on chromosome 4 with a LOD score of 2.49 under homogeneity. We then analysed the germline DNA of two patients from each family using exome sequencing. Initially focusing on the linkage region, no potentially pathogenic variants could be identified in more than one family. Variants outside the linkage region were then analysed, and we detected multiple possibly pathogenic variants in genes that encode DNA integrity maintenance proteins. However, further analysis led to the rejection of all variants due to poor co-segregation or a relatively high allele frequency in a control population. We concluded that using CGH results to focus on a sub-set of families for sequencing analysis did not enable us to identify a common genetic change responsible for the aggregation of breast cancer in these families. Our data also support the emerging view that non-BRCA1/2 hereditary breast cancer families have a very heterogeneous genetic basis.
authors: Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands. f.s.m.hilbers@lumc.nl
authors: Florentine S
authors: FS
authors: Hilbers
authors: Caro M
authors: CM
authors: Meijers
authors: Jeroen F J
authors: JF
authors: Laros
authors: Michiel
authors: M
authors: van Galen
authors: Nicoline
authors: N
authors: Hoogerbrugge
authors: Hans F A
authors: HF
authors: Vasen
authors: Petra M
authors: PM
authors: Nederlof
authors: Juul T
authors: JT
authors: Wijnen
authors: Christi J
authors: CJ
authors: van Asperen
authors: Peter
authors: P
authors: Devilee
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D002894:Chromosomes, Human, Pair 4; D055028:Comparative Genomic Hybridization; D059472:Exome; D005190:Family; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D008040:Genetic Linkage; D018095:Germ-Line Mutation; D006801:Humans; D008126:Lod Score; D016366:Open Reading Frames; D010375:Pedigree; D017422:Sequence Analysis, DNA
references: Bioinformatics. 2009 Jul 15;25(14):1754-60
references: 19451168
references: Nature. 2010 Oct 28;467(7319):1061-73
references: 20981092
references: Cancer Genet Cytogenet. 2008 Apr 15;182(2):75-83
references: 18406868
references: Genes Chromosomes Cancer. 2008 Nov;47(11):947-56
references: 18663745
references: Annu Rev Genomics Hum Genet. 2008;9:321-45
references: 18544032
references: Nat Genet. 2003 Mar;33 Suppl:228-37
references: 12610532
references: Am J Hum Genet. 1996 Jun;58(6):1347-63
references: 8651312
references: Nat Methods. 2010 Apr;7(4):248-9
references: 20354512
references: Bioinformatics. 2009 Sep 1;25(17):2283-5
references: 19542151
references: Breast Cancer Res. 2011 Sep 20;13(5):R90
references: 21542898
references: Genome Res. 2011 Jun;21(6):936-9
references: 20980556
references: Br J Cancer. 2002 Jan 7;86(1):76-83
references: 11857015
references: Cancer Res. 2005 Sep 1;65(17):7612-21
references: 16140926
references: J Med Genet. 2012 Oct;49(10):618-20
references: 23054243
references: Am J Hum Genet. 2012 Apr 6;90(4):734-9
references: 22464251
references: Cancer Res. 2002 Dec 1;62(23):7110-7
references: 12460933
references: Am J Hum Genet. 2004 Jun;74(6):1175-82
references: 15122511
references: Clin Cancer Res. 2005 Feb 1;11(3):1146-53
references: 15709182
references: Science. 2012 May 11;336(6082):740-3
references: 22582263
references: Am J Hum Genet. 2001 Feb;68(2):420-31
references: 11133358
references: Int J Cancer. 2005 Mar 20;114(2):230-6
references: 15540206
references: Am J Hum Genet. 1984 Mar;36(2):460-5
references: 6585139
references: Am J Hum Genet. 1993 Apr;52(4):678-701
references: 8460634
references: Nat Genet. 2008 Jan;40(1):17-22
references: 18163131
references: Genet Epidemiol. 2001 Jul;21(1):1-18
references: 11443730
references: Cancer Res. 2005 Feb 1;65(3):822-7
references: 15705879
references: Breast Cancer Res Treat. 2012 Apr;132(2):379-89
references: 20614180
references: Nat Genet. 2010 Sep;42(9):790-3
references: 20711175
references: Expert Rev Anticancer Ther. 2009 Aug;9(8):1103-13
references: 19671030
references: Cancer Res. 1997 Apr 1;57(7):1222-7
references: 9102202
references: Science. 1994 Sep 30;265(5181):2088-90
references: 8091231
references: Nature. 2013 Jan 10;493(7431):216-20
references: 23201682
references: Nature. 2003 Dec 18;426(6968):789-96
references: 14685227
references: Breast Cancer Res Treat. 2009 Aug;116(3):479-89
references: 18704682
references: Breast Cancer Res Treat. 2011 Nov;130(2):425-36
references: 21286804